Results 251 to 260 of about 16,072,038 (292)

Association Between GGT/HDL-C Ratio and Diabetic Kidney Disease in Patients with Type-2 Diabetes Mellitus. [PDF]

Diabetes Metab Syndr Obes
Teng C, Lin H, Xu J, Wu X.
europepmc   +1 more source

HDL-C and Hematologic Malignancies: A Commentary on Cohort Study. [PDF]

J Lipid Atheroscler
Chung SM.
europepmc   +1 more source

Beyond inflammation and cholesterol: atherogenic index of plasma mediates the link between hsCRP/HDL-C ratio and depression in US adults NHANES 2015-2020. [PDF]

Ann Gen Psychiatry
Ma JY, Hu J, Tang F, Meng Y, Ye F, Hu LL, Zhang YH.   +6 more
europepmc   +1 more source

Correction to “The Dynamic Evolution of Lipid Profiles Following Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis”

Portal Hypertension &Cirrhosis, EarlyView.
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Changes in triglyceride, HDL-C, and non-HDL-C levels in patients with acute coronary syndrome

Wiener klinische Wochenschrift, 2016
Changes in high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG) levels have been linked to residual cardiovascular risk, whereas non-HDL-C levels have been shown to be more predictive of cardiovascular risk than are low-density lipoprotein cholesterol (LDL-C) levels. We aimed to investigate the impact of HDL-C, TG, and non-HDL-C levels on
Péter, Koncsos, Péter, Fülöp, Imre, Juhász, Klára, Bíró, László, Márk, Gábor, Simonyi, György, Paragh   +6 more
openaire   +2 more sources

Effectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-C

Current Medical Research and Opinion, 2004
To evaluate the efficacy of high and moderate doses of simvastatin (80 and 40 mg), for raising high density lipoprotein-cholesterol (HDL-C), improving HDL sub-fractions, and affecting other parameters, including high sensitivity C-reactive protein (hs-CRP), in patients with type 2 diabetes mellitus (DM) and low HDL-C.This double-blind, placebo ...
Michael, Miller, Adrian, Dobs, Zhong, Yuan, Wendy P, Battisti, Hannah, Borisute, Joanne, Palmisano   +5 more
openaire   +2 more sources

New Drugs for HDL-C Disorders: The Beginning

Current Medicinal Chemistry, 2014
For more than 20 years there has been increasing interest in the development of novel therapies to raise levels of high-density lipoprotein cholesterol (HDL-C). However, well publicized failures of recent clinical trials of agents that raise HDL-C levels have stimulated considerable controversy with regard to the potential clinical utility of this ...
Duong, M., Nicholls, S.
openaire   +3 more sources